SUN-094 Long-Term Safety and Efficacy of Leuprorelin in Treating Central Precocious Puberty: A Large, Open-Label, Multicenter, Phase IV Study in China

BACKGROUND: Leuprorelin (Enantone®) is a gonadotropin-releasing hormone (GnRH) analogue used worldwide to treat central precocious puberty (CPP). This clinical trial aimed to evaluate the long-term safety and efficacy of leuprorelin in treating Chinese CPP children. Methods: This is the first, prosp...

Descripción completa

Detalles Bibliográficos
Autores principales: Luo, Xiaoping, Hou, Ling, Zhong, Yan, Yang, Yu, Li, Pin, Qiu, Wenjuan, Liu, Ying, Luo, Feihong, Hu, Yuhua, Wang, Qing, Du, Hongwei, Fu, Junfen, Wang, Winston
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2020
Materias:
Pediatric Endocrinology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7208757/
http://dx.doi.org/10.1210/jendso/bvaa046.571

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7208757/
http://dx.doi.org/10.1210/jendso/bvaa046.571

Ejemplares similares